Salvage Radiotherapy for Patients with PSA Relapse Following Radical Prostatectomy: Issues and Challenges
Richard Choo
Cancer Res Treat. 2010;42(1):1-11.   Published online 2010 Mar 31     DOI: https://doi.org/10.4143/crt.2010.42.1.1
Citations to this article as recorded by Crossref logo
Hypofractionated Radiation Therapy to the Prostate Bed With Intensity-Modulated Radiation Therapy (IMRT): A Phase 2 Trial
Elton Trigo Teixeira Leite, Clarissa Cerchi Angotti Ramos, Victor Augusto Bertotti Ribeiro, Bernardo Peres Salvajoli, William Carlos Nahas, João Victor Salvajoli, Fabio Ynoe Moraes
International Journal of Radiation Oncology*Biology*Physics.2021; 109(5): 1263.     CrossRef
Elective pelvic irradiation in prostate cancer patients with biochemical failure following radical prostatectomy: A propensity score matching analysis
Changhoon Song, Sang Jun Byun, Young Seok Kim, Hanjong Ahn, Seok-Soo Byun, Choung-Soo Kim, Sang Eun Lee, Jae-Sung Kim, Christopher J.D. Wallis
PLOS ONE.2019; 14(4): e0215057.     CrossRef
Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial
Christian Carrie, Nicolas Magné, Patricia Burban-Provost, Paul Sargos, Igor Latorzeff, Jean-Léon Lagrange, Stéphane Supiot, Yazid Belkacemi, Didier Peiffert, Nedla Allouache, Bernard M Dubray, Stéphanie Servagi-Vernat, Jean-Philippe Suchaud, Gilles Crehan
The Lancet Oncology.2019; 20(12): 1740.     CrossRef
Clinical impact of PSMA-based 18F–DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy
Esther Mena, Maria L. Lindenberg, Joanna H. Shih, Stephen Adler, Stephanie Harmon, Ethan Bergvall, Deborah Citrin, William Dahut, Anita T. Ton, Yolanda McKinney, Juanita Weaver, Philip Eclarinal, Alicia Forest, George Afari, Sibaprasad Bhattacharyya, Ronn
European Journal of Nuclear Medicine and Molecular Imaging.2018; 45(1): 4.     CrossRef
Recent advances in radiation oncology: multimodal targeting of high risk and recurrent prostate cancer
Young Kwok, Adeel Kaiser, Stephanie R. Rice, Randi Cohen, Mark Mishra
Current Opinion in Oncology.2018; 30(3): 165.     CrossRef
Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer
Oladunni O. Akin-Akintayo, Ashesh B. Jani, Oluwaseun Odewole, Funmilayo I. Tade, Peter T. Nieh, Viraj A. Master, Leah M. Bellamy, Raghuveer K. Halkar, Chao Zhang, Zhengjia Chen, Mark M. Goodman, David M. Schuster
Clinical Nuclear Medicine.2017; 42(1): e22.     CrossRef
The Trend of Uro-Oncologist About Blood Test and Imaging Studies for the Diagnosis of Biochemical Recurrence in Korea
Sung Pil Seo, Won Tae Kim, Ho Won Kang, Yong-June Kim, Sang-Cheol Lee, Wun-Jae Kim, So Young Kim, Jong-Hyock Park, Seok Joong Yun
The Korean Journal of Urological Oncology.2017; 15(3): 131.     CrossRef
Prognostic factors after salvage radiotherapy alone in patients with biochemical recurrence after radical prostatectomy
Wan Song, Hwang Gyun Jeon, Hyun Hwan Sung, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Han Yong Choi, Hyun Moo Lee
International Journal of Urology.2016; 23(1): 56.     CrossRef
Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial
Christian Carrie, Ali Hasbini, Guy de Laroche, Pierre Richaud, Stéphane Guerif, Igor Latorzeff, Stéphane Supiot, Mathieu Bosset, Jean-Léon Lagrange, Véronique Beckendorf, François Lesaunier, Bernard Dubray, Jean-Philippe Wagner, Tan Dat N'Guyen, Jean-Phil
The Lancet Oncology.2016; 17(6): 747.     CrossRef
Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial
Eduard Schreibmann, David M. Schuster, Peter J. Rossi, Joseph Shelton, Sherrie Cooper, Ashesh B. Jani
International Journal of Radiation Oncology*Biology*Physics.2016; 96(1): 206.     CrossRef
Detection of a second malignancy in prostate cancer patients by using [18F]Choline PET/CT: a case series
Martina Sollini, Francesco Pasqualetti, Marzio Perri, Gabriele Coraggio, Paolo Castellucci, Massimo Roncali, Roberto Boni, Elena Lazzeri, Maria Galeandro, Fabiola Paiar, Annibale Versari, Paola Anna Erba
Cancer Imaging.2016;[Epub]     CrossRef
Radiosensitization by the investigational NEDD8-activating enzyme inhibitor MLN4924 (pevonedistat) in hormone-resistant prostate cancer cells
Xiaofang Wang, Wenjuan Zhang, Zi Yan, Yupei Liang, Lihui Li, Xiaoli Yu, Yan Feng, Shen Fu, Yanmei Zhang, Hu Zhao, Jinha Yu, Lak Shin Jeong, Xiaomao Guo, Lijun Jia
Oncotarget.2016; 7(25): 38380.     CrossRef
Current status and outcomes of patients developing PSA recurrence after prostatectomy who were treated with salvage radiotherapy: a JROSG surveillance study
Takashi Mizowaki, Manabu Aoki, Katsumasa Nakamura, Atsunori Yorozu, Masaki Kokubo, Katsuyuki Karasawa, Takuyo Kozuka, Nobuaki Nakajima, Keisuke Sasai, Tetsuo Akimoto
Journal of Radiation Research.2015; 56(4): 750.     CrossRef
Utilization of PSA measurement at three months following salvage radiation therapy to predict future biochemical outcome
Michael G. Heckman, Katherine S. Tzou, Colleen S. Thomas, Thomas M. Pisansky, Steven E. Schild, William W. Wong, Richard J. Lee, Melanie C. Bois, Waleed Brinjikji, Jennifer L. Peterson, Larry C. Daugherty, Stephen J. Ko, Steven J. Buskirk
Journal of Radiation Oncology.2014; 3(1): 81.     CrossRef
Anti-3-[ 18 F]FACBC Positron Emission Tomography-Computerized Tomography and 111 In-Capromab Pendetide Single Photon Emission Computerized Tomography-Computerized Tomography for Recurrent Prosta
David M. Schuster, Peter T. Nieh, Ashesh B. Jani, Rianot Amzat, F. DuBois Bowman, Raghuveer K. Halkar, Viraj A. Master, Jonathon A. Nye, Oluwaseun A. Odewole, Adeboye O. Osunkoya, Bital Savir-Baruch, Pooneh Alaei-Taleghani, Mark M. Goodman
Journal of Urology.2014; 191(5): 1446.     CrossRef
Salvage Low-Dose-Rate Brachytherapy for Prostate Cancer Local Recurrence after Radical Prostatectomy: Our First three Patients
Emilio Gastaldi, Fabrizio Gallo, Luciano Chiono, Claudio Giberti
Urologia Journal.2014; 81(1): 46.     CrossRef
Lack of association between COX-2 staining level and biochemical recurrence following salvage radiation therapy for recurrent prostate cancer
Michael G. Heckman, Katherine S. Tzou, Alexander S. Parker, Thomas M. Pisansky, Steven E. Schild, Tracy W. Hilton, Vivek N. Patel, Liset Pelaez, Li Yan Khor, Jennifer L. Peterson, Larry C. Daugherty, Laura A. Vallow, Alan Pollack, Steven J. Buskirk
Journal of Radiation Oncology.2013; 2(3): 309.     CrossRef
Treatment of men with rising prostate-specific antigen levels following radical prostatectomy
Katherine Tzou, Winston W Tan, Steven Buskirk
Expert Review of Anticancer Therapy.2011; 11(1): 125.     CrossRef
Detection of Recurrent Prostate Carcinoma withanti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid PET/CT and111In–Capromab Pendetide SPECT/CT
David M. Schuster, Bital Savir-Baruch, Peter T. Nieh, Viraj A. Master, Raghuveer K. Halkar, Peter J. Rossi, Melinda M. Lewis, Jonathon A. Nye, Weiping Yu, F. DuBois Bowman, Mark M. Goodman
Radiology.2011; 259(3): 852.     CrossRef
EUS-guided fiducial placement after radical prostatectomy before targeted radiation therapy for prostate cancer recurrence
Julie Yang, May Abdel-Wahab, Afonso Ribeiro
Gastrointestinal Endoscopy.2011; 73(6): 1302.     CrossRef